NCT03656003
- Conditions
- Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +4 more
- Locations
-
- Bronchoscopy suite, PGIMER Chandigarh, India
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,094 public trials
2,044 recruiting studies
Lymphoproliferative Disorders trial results
NCT02273739
- Conditions
- Adenocarcinoma, Angioimmunoblastic T-cell Lymphoma, Carcinoma, +22 more
- Locations
-
- Los Angeles, California, United States
- Los Angeles, California, United States
- Miami, Florida, United States
- Baltimore, Maryland, United States
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Investigational Site Number 056002 Bruges, Belgium
- Investigational Site Number 233001 Tallinn, Estonia
- Investigational Site Number 440001 Vilnius, Lithuania
- Investigational Site Number 752001 Stockholm, Sweden
Completed
Bendamustine Bridge to Autologous or Allogeneic Transplant for Relapsed/Refractory Lymphoma
NCT02059239
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +9 more
- Locations
-
- Weill Cornell Medical College New York, United States
NCT01169532
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Fox Chase Cancer Center Rockledge, Pennsylvania, United States
NCT01327612
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +44 more
- Locations
-
- Research Site Duarte, California, United States
- Research Site La Jolla, California, United States
- Research Site Denver, Colorado, United States
- Research Site Tampa, Florida, United States
NCT02078102
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
NCT02740270
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Novartis Investigative Site Chicago, Illinois, United States
- Novartis Investigative Site Boston, Massachusetts, United States
- Novartis Investigative Site New York, United States
- Novartis Investigative Site Houston, Texas, United States
NCT00003650
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Centre Leon Berard Lyon, France
NCT01025778
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Graft vs Host Disease, +15 more
- Locations
-
- Lund University Hospital Lund, Sweden